Hyep Ivan, Chief Financial Officer of BCAX, has demonstrated a clear selling bias in recent insider transactions, with no purchases recorded in the past year. Since October 2025, Ivan has executed 24 trades exclusively involving BCAX shares, with $1.69 million in total sales outweighing $348,661 in buy activity. The selling trend intensified in early 2026, with 11 disposals including three major transactions on March 3 ($246,909), March 4 ($54,061), and March 23 ($170,348). These sales followed earlier clusters in October and November 2025, when Ivan disposed of $653,129 worth of shares across seven transactions, including a $332,385 sale on October 7.
The transactions show a consistent pattern of paired sales (coded "S") with smaller, corresponding market purchases (coded "M"), typically representing 15-20% of the sale value. For example, the March 23 $170,348 sale was accompanied by a $34,866 acquisition, while the November 24, 2025, $330,093 disposition had a $67,439 buy component. This suggests Ivan may be rebalancing positions while maintaining some exposure. All activity has been concentrated in BCAX, with no diversification into other securities. The absence of any recent buys and the acceleration of sales in Q1 2026 indicate a sustained reduction in holdings.
AI-assisted summary